US-Listed Biological Products, (No Diagnostic Substances) (SIC 2836)
303 US filers with SEC EDGAR filings in the FACTANKER registry.
Benchmark pages
- Revenue percentiles — US-listed Biological Products, (No Diagnostic Substances)
- Net Income percentiles — US-listed Biological Products, (No Diagnostic Substances)
- Operating Income percentiles — US-listed Biological Products, (No Diagnostic Substances)
- Total Assets percentiles — US-listed Biological Products, (No Diagnostic Substances)
- EBITDA Margin percentiles — US-listed Biological Products, (No Diagnostic Substances)
Largest companies (latest fiscal-year revenue)
- Amgen Inc. $36.8B revenue
- GILEAD SCIENCES, INC. $29.4B revenue
- BIOGEN INC. $9.9B revenue
- NEUROCRINE BIOSCIENCES INC $2.9B revenue
- Exelixis Inc $2.3B revenue
- QIAGEN N.V. $2.1B revenue
- Moderna, Inc. $1.9B revenue
- HALOZYME THERAPEUTICS, INC. $1.4B revenue
- Bio-Techne Corporation $1.2B revenue
- Novavax, Inc. $1.1B revenue
Machine access — free, no API key
Every figure shown here about Biological Products, (No Diagnostic Substances) — Benchmarks can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.
These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.